THE
FUTURE
OF ABLATION

100 + patients
treated

All forms of ablation today are thermal. While both radiofrequency and cryo ablation have evolved, they nonetheless carry an inherent risk of indiscriminate damage.

FARAPULSE

PULSED FIELD ABLATION

This is why Pulsed Field Ablation (PFA) has emerged to be the most promising energy source for cardiac ablation, including pulmonary vein isolation. Combining speed with safety, PFA makes durable lesions in a manner of micro-seconds while sparing non-target tissue.

THE DISCRIMINATING ENERGY SOURCE

The true advantage of PFA is its discriminant mode of action. Unlike thermal ablation which destroys all cells in and around the targeted area, PFA is highly tissue specific.

Various tissue types within the heart, including nerve, blood vessel, collagen and endothelium have different tolerances to PFA. Likewise, other structures adjacent to the heart such as the esophagus and phrenic nerve have different tolerances to PFA dosing. Since the electric field threshold that ablates myocardial cells is much lower than other tissues, PFA ablates myocardium without harming critical adjacent structures.

THE FREEDOM TO ABLATE WITH CONFIDENCE

FARAPULSE UPDATES

JACC 2019

Go

CME SYMPOSIUM WEBCAST

Go

FDA BREAKTHROUGH

Go

MRI ANALYSIS OF PFA

Go

THE ABILITY TO ABLATE NEAR VITAL STRUCTURES

PRODUCTS

Through optimized delivery and purpose-built hardware, FARAPULSE is advancing its tissue-selective PFA therapy on catheter and surgical platforms, for both endocardial and epicardial approaches.

ENDO

FARAWAVE is an over-the-wire catheter designed to create transmural and circumferential PFA lesions from a femoral approach. Its distal end offers variable morphology designed to treat each patient’s pulmonary vein anatomy with uncompromising and consistent results.

ENDO

FARAFLEX is a deflectable catheter allowing flexible, focal placement of PFA therapy, including strategies beyond pulmonary vein isolation.

EPI

FARAONE creates a rapid, transmural and circumferential lesion around all the pulmonary veins and posterior wall of the left atrium. The catheter is surgically placed with the intent to electrically isolate these structures in micro-seconds, from an epicardial approach and without the need for cardiopulmonary bypass.

SAFETY, SPEED, EFFICACY

FARAPULSE ENDEAVOR

Our team is dedicated to bringing FARAPULSE PFA into EP labs across the globe. Tissue-selective. Rapid. Effective. That’s the future of cardiac ablation.

Charles Eggert

Charles Eggert

Joan Simon

Joan Simon

Allan Zingeler

Allan Zingeler

Raju Viswanathan

Raju Viswanathan

Mark Wisniewski

Mark Wisniewski

Richard S. Brose

Richard S. Brose

Hilman Chung

Hilman Chung

Nayirie Tashjian

Nayirie Tashjian

Bob Fowler

Bob Fowler

Kit Schneider

Kit Schneider

John Madden

John Madden

Rosa Barriga

Rosa Barriga

Mike Paré

Mike Paré

Anitha Achyutha

Anitha Achyutha

Eric Buck

Eric Buck

John Lehmann

John Lehmann

Anusha Chinthapally

Anusha Chinthapally

Bin Chen

Bin Chen

Richard Kimura

Richard Kimura

Jessica Africa

Jessica Africa

Gary Long

Gary Long

Michael Wiley

Michael Wiley

NEWS/CONTACT

NEWS RELEASES

Read more

GENERAL INFORMATION

info@farapulse.com

PHONE

650.422.3633

OFFICE

3715 Haven Ave, Suite 110
Menlo Park, CA 94025

Farapulse